Turnium Partners with Syntheia for AI-Driven Communications (TSXV:TTGI)

Vancouver, Canada — December 18, 2025 — Leads & Copy — Turnium Technology Group Inc. (TSXV: TTGI) (FSE: E48) has announced a global commercialization partnership with Syntheia Corp. (CSE: SYAI), a provider of conversational AI solutions for telephone call management.

According to the company, this milestone follows Turnium’s previously announced strategic alliance with Syntheia AI, and marks the transition from collaboration to revenue generation. Turnium’s channel partners will now have access to the platform as a value-added solution intended to enhance business communications, customer engagement, and operational efficiency.

The Syntheia platform enables partners to deploy conversational AI for both outbound and inbound business communications, automating high-volume and repetitive communication workflows, allowing businesses to remain responsive and consistent while reducing operational strain.

Outbound use cases include business development and lead engagement, accounts receivable and payment follow-ups, and appointment confirmations and proactive customer outreach.

Inbound use cases feature customer support and troubleshooting, order status and service updates, and call routing and first-level response automation.

Turnium’s Global CEO Doug Childress said that their partners are constantly looking for ways to deliver more value without adding complexity. He added that the commercialization of Syntheia’s AI communications platform will sit within their TaaS ecosystem and provide their partners a practical, revenue-ready solution that addresses real business needs—from sales outreach to customer support—using AI.

Tony Di Benedetto, Chairman and CEO of Syntheia AI, said that this commercial rollout represents a major milestone for Syntheia. He added that through Turnium’s global partner network, their platform can now be deployed at scale, enabling partners and their customers to modernize how they communicate with clients, prospects, and stakeholders.

The platform has been structured for easy integration into partner environments, with flexible usage models and support for multi-industry deployments. Initial rollouts will focus on select partners, with broader availability planned as adoption expands.

The company says that this commercialization initiative reinforces Turnium’s strategy of delivering differentiated, AI-enabled solutions that drive partner growth and recurring revenue while strengthening customer relationships.

Syntheia is an artificial intelligence technology company which is developing and commercializing proprietary algorithms to deliver human-like conversations and deploying our technology to enhance customer satisfaction while dramatically reducing turnover and traditional staffing issues.

Turnium Technology Group Inc. (TTGI) acquires companies that complement its Technology-as-a-Service (TaaS) strategy, integrates them to generate efficiencies, and delivers their solutions through a global channel partner program to customers worldwide. TTGI’s mission is to provide IT providers with a complete, white-labelled portfolio of business technology solutions, enabling them to quickly add new services in response to customer demand.

In essence, Turnium is building a TaaS platform that incorporates all the services, platforms, and capabilities that ISPs, MSPs, IT Providers, VoIP/UCaaS, CCaaS, or Cloud Providers might need. Additionally, Turnium provides deployment resources, hardware, delivery, support, and marketing and sales enablement to help channel partners go to market quickly and deliver exceptional quality.

Turnium delivers secure, cost-effective, uninterrupted, and scalable global IT solutions to its channel partners and their end-customers.

Turnium Contact:
Investor Relations: Bill Mitoulas
Email: investor.relations@ttgi.io
Telephone: +1 416-479-9547
Media inquiries: please email media@ttgi.io
Sales inquiries: please email sales@ttgi.io

Source: Turnium Technology Group Inc.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.